Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies

por Howard, Campbell, Noe, Adele, Skerjanec, Andrej, Holzhauer, Björn, Wernsing, Margaret, Ligueros-Saylan, Monica, Thuren, Tom
Publicado 2014

Effects of subcutaneous pasireotide on cardiac repolarization in healthy volunteers: A single-center, phase I, randomized, four-way crossover study

por Breitschaft, Astrid, Hu, Ke, Darstein, Christelle, Ligueros-Saylan, Monica, Jordaan, Pierre, Song, Dongweon, Hudson, Michelle, Shah, Rashmi
Publicado 2014

Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing’s disease: results from an open-ended, open-label extension tri...

por Schopohl, Jochen, Gu, Feng, Rubens, Robert, Van Gaal, Luc, Bertherat, Jérôme, Ligueros-Saylan, Monica, Trovato, Andrew, Hughes, Gareth, Salgado, Luiz R., Boscaro, Marco, Pivonello, Rosario
Publicado 2014

Dipeptidyl Peptidase-4 Inhibition by Vildagliptin and the Effect on Insulin Secretion and Action in Response to Meal Ingestion in Type 2 Diabetes

por Dalla Man, Chiara, Bock, Gerlies, Giesler, Paula D., Serra, Denise B., Ligueros Saylan, Monica, Foley, James E., Camilleri, Michael, Toffolo, Gianna, Cobelli, Claudio, Rizza, Robert A., Vella, Adrian
Publicado 2009

Real-World Safety and Effectiveness of Omalizumab in Moderate to Severe Allergic Asthma Patients in China: A Post-Authorization Study

por Su, Nan, Zhi, Lili, Liu, Fengxia, Wang, Yongsheng, Zhang, Qingling, Liu, Xiansheng, Wang, Xueyan, Hao, Guodong, Zhang, Xiuqin, Hu, Qiang, Ligueros-Saylan, Monica, Uddin, Alkaz, Yang, Jing, Liang, Tiantian, Ding, Liju, Li, Runqin, Wang, Chen
Publicado 2023

Efficacy and safety of omalizumab in Chinese patients with anti‐histamine refractory chronic spontaneous urticaria

por Yuan, Weiru, Hu, Shuling, Li, Min, Yang, Lijia, Liu, Lingling, Zheng, Min, Guo, Zaipei, Song, Zhiqiang, Zhang, Chunlei, Diao, Qingchun, Xu, Jinhua, Richard, Alexia, Patwardhan, Moreshwar, Lyu, Tianmeng, Uddin, Alkaz, Fogel, Robert, Ligueros‐Saylan, Monica, Zheng, Jie
Publicado 2022

Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH)

por Wood, Robert A., Chinthrajah, R. Sharon, Rudman Spergel, Amanda K., Babineau, Denise C., Sicherer, Scott H., Kim, Edwin H., Shreffler, Wayne G., Jones, Stacie M., Leung, Donald Y.M., Vickery, Brian P., Bird, J. Andrew, Spergel, Jonathan M., Kulis, Michael, Iqbal, Ahmar, Kaufman, Derrick, Umetsu, Dale T., Ligueros-Saylan, Monica, Uddin, Alkaz, Fogel, Robert B., Lussier, Stephanie, Mudd, Kim, Poyser, Julian, MacPhee, Martin, Veri, Maria, Davidson, Wendy, Hamrah, Sanaz, Long, Andrew, Togias, Alkis
Publicado 2022